Overview / Abstract: |
Live and Via Webinar Learning Objectives: • Describe the mechanism of PCSK9 inhibitors and their effects on lipids Target Audience: Program components are: Pre-test Achieving a passing score of the assessment post-test is not a requirement of obtaining continuing education credit; however participating in all active learning components is. Questions: Please email pharmacyce@buffalo.edu |
Expiration |
Mar 07, 2019 |
Discipline(s) |
Pharmacy CPE |
Format |
Live / Seminar, Webinar / Webcast / Video |
Cost |
$25 |
Credits / Hours |
1 contact hour, 0.1 ceus |
Accreditation |
ACPE |
Is This Activity Certified for "Live" Credit? |
YES |
Presenters / Authors / Faculty |
Hailey Lipinski, PharmD PGY2 Ambulatory Care Pharmacy Resident Buffalo Medical Group |
Activity Specialities / Related Topics |
Cardiology / Cardiovascular |
Keywords / Search Terms |
University at Buffalo School of Pharmacy Cardiology, lipid control, PCSK9 inhibitors, cardiovascular outcomes, evolocumab, alirocumab Live CE CME Seminar CE CME |
LIVE Activity Location Details |
Date(s)
University at Buffalo School of Pharmacy and Pharmaceutical Sciences, 250 Kapoor Hall |